FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, specifically to a new compound - di-3-(3,5-di-tert-butyl-4-hydroxyphenyl)-2-hydroxy-1-(N-isopropylamino)propane succinate 
with antiarrhythmic and antihypertensive activity. The compound (1) is three-stage synthesised. At the first stage, ethylene chlorohydrin and tin tetrachloride are added to 2,6-di-tert-butylphenol solution in trichloroethylene. The prepared compound is heated with isopropyl amine that leads to formation of related amine. An end-product succinate (1) is prepared by mixing of amine solution and succinic acid in acetone wherein succinate (1) is precipitated as white crystals.
EFFECT: preparation of the compound with antiarrhythmic and antihypertensive activity.
3 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| FLUORATED 4-FURFURYL-3,4-DIHYDRO-2H-BENZO[1,4]THIAZINE-1,1-DIOXIDES WITH HIGH ARRYTHMIC ACTIVITY | 2016 |
|
RU2626239C1 |
| 5'-BROMOLAPPACONITINE HYDROBROMIDE POSSESSING ANTI-ARRHYTHMIC ACTIVITY | 2005 |
|
RU2295524C1 |
| BIS- (3- (3,5-DI-TERT-BUTYL-4-HYDROXYPHENYL) PROPYL) SELENIDE, HAVING ANTIOXIDANT AND HYPOGLYCEMIC ACTIVITY | 2015 |
|
RU2586067C1 |
| 16-{2-BENZOYLAMINO-2-[(3,5-DI-TRET-BUTHYL-4-HYDROXUPHENYL)ALKYL-CARBAMOYL]VINYL}-LABDATRIENS WITH ANTIOXIDANT, HEPATOPROTECTION AND HEMOSTIMULATING EFFECT | 2007 |
|
RU2346940C1 |
| METHODS OF HEARTBEAT FREQUENCY REDUCTION INCLUDING ADMINISTRATION OF ADENOSINE A RECEPTOR AGONIST TOGETHER WITH BETA-BLOCKER, CALCIUM CANAL BLOCKER OR CARDIAC GLYCOSIDE | 2003 |
|
RU2332220C2 |
| CURABLE COMPOSITION HAVING THERMOLATENT BASE | 2009 |
|
RU2487867C2 |
| VERSIONS OF METHOD OF PRODUCING N-(3-ALKYLAMINOPROPIL)-NЪ-PHENYLUREA OR PHARMACOLOGICALLY ACCEPTABLE SALTS THEREOF | 0 |
|
SU1344245A3 |
| PULMONARY METASTASIS INHIBITOR | 2021 |
|
RU2765955C1 |
| (1-HYDROXY-4,5-DIMETHYL-1H-IMIDAZOL-2-YL)(PHENYL)METHANONOXIME EXHIBITING ANTIARRHYTHMIC PROPERTIES | 2012 |
|
RU2478622C1 |
| MEANS FOR INHIBITING METASTASIS IN THE LUNGS | 2021 |
|
RU2762730C1 |
